Bariatric surgery in patients with late-stage type 2 diabetes: expected beneficial effects on risk ratio and outcomes

Diabetes and Metabolism

Volumn 35, Issue 6 PART II, 2009, Pages 564-568

  Renard, E ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Bariatric surgery; Obesity; Review; Type 2 diabetes

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; BARIATRIC SURGERY; DIABETES CONTROL; HUMAN; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; RISK ASSESSMENT; WEIGHT REDUCTION;

EID: 75249103290     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(09)73467-6     Document Type: Article

References (30)

1. Yoon K., Lee J.H., Kim J.W., Cho J.H., Choi Y.H., Ko S.H., et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 368 (2006) 1681-1686
2. Leibson C.L., Williamson D.F., Melton III L.J., Palumbo P.J., Smith S.A., Ransom J.E., et al. Temporal trends in BMI among adults with diabetes. Diabetes Care 24 (2001) 1584-1589
3. Purnell J.Q., Kahn S.E., Albers J.J., Nevin D.N., Brunzell J.D., and Schwartz R.S. Effect of weight loss with reduction of intra-abdominal fat in lipid metabolism in older men. J Clin Endocrinol Metab 85 (2000) 977-982
4. Goodpaster B.H., Theriault R., Watkins S.C., and Kelley D.E. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49 (2000) 467-472
5. Kotronen A., Seppälä-Lindroos A., Bergholm R., and Yki-Järvinen H. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia 51 (2008) 130-138
6. Schernthaner G., and Morton J.M. Bariatric surgery in patients with morbid obesity and type 2 diabetes. Diabetes Care 31 Suppl 2 (2008) S297-S302
7. Sjöström L., Narbro K., Sjöström C.D., Karason K., Larsson B., Wedel H., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 753-761
8. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
9. Ferrannini E., and Mingrone G. Impact of different bariatric surgical peocedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care 32 (2009) 514-520
10. Schauer P.R., Burguera B., Ikramuddin S., Cottam D., Gourash W., Hamad G., et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238 (2003) 467-485
11. Dixon J.B., and O'Brien P.E. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 25 (2002) 358-363
12. Maggard M., Shugarman L., Suttorp M., Maglione M., Sugerman H.J., Livingston E.H., et al. Meta-analysis: surgical treatment for obesity. Ann Intern Med 142 (2005) 547-559
13. Puzziferri N., Austrheim I.T., Wolfe B.M., Wilson S.E., and Hguyen N.T. Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass. Ann Surg 243 (2006) 181-188
14. Flum D.R., Salem L., Brockel Elrod J., Dellinger E.P., Cheadle A., and Chan L. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA 294 (2005) 1903-1908
15. Livingston E.H., and Ko C.Y. Assessing the relative contribution of individual risk factors on surgical outcome for gastric bypass surgery: a baseline probability analysis. J Surg Rsch 105 (2002) 48-52
16. Fernandez A.Z., DeMaria E.J., Tichansky D.S., Kellum J.M., Wolfe L.G., Meador J., et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg 239 (2004) 698-703
17. Van Hout G.C., Verschure S.K., and van Heck G.L. Psychosocial predictors of success following bariatric surgery. Obes Surg 15 (2005) 552-560
18. Buchwald H., Estok R., Fahrbach K., Banel D., Jensen M.D., Pories W.J., et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122 (2009) 248-256
19. MacDonald K.G., Long S.D., Swanson M.S., Brown B.M., Morris P., Dohm L., et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1 (1997) 213-220
20. Pories W.J., Swanson M.S., MacDonald K.G., Long S.B., Morris P.G., Brown B.M., et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222 (1995) 339-350
21. Henry R.R., Scheaffer L., and Olefsky J.M. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 61 (1985) 917-925
22. Kelley D.E., Wing R., Buonocore C., Sturis J., Polonsky K., and Fitzsimmons M. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77 (1993) 1287-1293
23. Ballantyne G.H., Farkas D., Laker S., and Wasiliewski A. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg 16 (2006) 1520-1525
24. Rubino F., Forgione A., Cummings D.E., Vix M., Gnuli D., Mingrone G., et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244 (2006) 741-749
25. Troy S., Soty M., Ribeiro L., Laval L., Migrenne S., Fioramonti X., et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 8 (2008) 201-211
26. Briatore L., Salani B., Andraghetti G., Danovaro C., Sferrazzo E., Scopinaro N., et al. Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. Obesity 16 (2008) 77-81
27. Laferrère B., Teixeira J., McGinty J., Tran H., Egger J.R., Colarusso A., et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 93 (2008) 2479-2485
28. Thaler J.P., and Cummings D.E. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150 (2009) 2518-2525
29. Gerstein H.C., Miller M.E., Byington R.P., Goff Jr. D.C., Bigger J.T., et al., Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
30. Keating C.L., Dixon J.B., Moodie M.L., Peeters A., Bulfone L., Maglianno D.J., et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modelled lifetime analysis. Diabetes Care 32 (2009) 567-574